ifosfamide has been researched along with Rheumatoid Arthritis in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"Patients having rheumatoid arthritis (RA) treated with methotrexate (MTX) are at an increased risk of developing lymphoproliferative disorder (LPD)." | 3.81 | Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs. ( Fukayama, M; Koda, K; Tajima, S; Takanashi, Y, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tajima, S | 1 |
Takanashi, Y | 1 |
Koda, K | 1 |
Fukayama, M | 1 |
Ströbel, G | 1 |
Dreher, R | 1 |
2 other studies available for ifosfamide and Rheumatoid Arthritis
Article | Year |
---|---|
Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Asparaginase; Diagnosis, Differential; Epstein-Barr Vi | 2015 |
[Number of T and B-lymphocytes in the peripheral blood in rheumatoid arthritis relative to the disease activity, the serum immunoglobulin level and the drug therapy].
Topics: Arthritis, Rheumatoid; Azathioprine; B-Lymphocytes; Cell Count; Gold; Humans; Ifosfamide; Immunoglob | 1978 |